Geode Capital Management LLC Has $8.93 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)

Geode Capital Management LLC increased its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 1.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 974,302 shares of the medical instruments supplier’s stock after acquiring an additional 13,535 shares during the period. Geode Capital Management LLC owned about 2.41% of AngioDynamics worth $8,927,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. State Street Corp grew its holdings in shares of AngioDynamics by 2.7% during the third quarter. State Street Corp now owns 810,372 shares of the medical instruments supplier’s stock worth $6,305,000 after purchasing an additional 21,218 shares during the last quarter. Barclays PLC lifted its position in AngioDynamics by 81.0% during the 3rd quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier’s stock worth $651,000 after buying an additional 37,394 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in AngioDynamics by 28.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier’s stock worth $4,304,000 after acquiring an additional 123,271 shares during the last quarter. Moody National Bank Trust Division increased its position in AngioDynamics by 70.2% in the 4th quarter. Moody National Bank Trust Division now owns 55,780 shares of the medical instruments supplier’s stock valued at $511,000 after acquiring an additional 23,003 shares in the last quarter. Finally, SG Americas Securities LLC raised its stake in shares of AngioDynamics by 21.3% in the fourth quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier’s stock worth $147,000 after acquiring an additional 2,832 shares during the last quarter. 89.43% of the stock is owned by institutional investors and hedge funds.

AngioDynamics Stock Up 0.6 %

ANGO stock opened at $9.36 on Thursday. AngioDynamics, Inc. has a twelve month low of $5.47 and a twelve month high of $13.50. The company has a market cap of $379.88 million, a P/E ratio of -1.66 and a beta of 0.52. The business has a fifty day moving average of $9.60 and a 200-day moving average of $9.06.

AngioDynamics (NASDAQ:ANGO) last announced its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.16. AngioDynamics had a negative return on equity of 7.26% and a negative net margin of 79.38%. The firm had revenue of $72.00 million during the quarter, compared to analysts’ expectations of $70.30 million. AngioDynamics’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, equities research analysts anticipate that AngioDynamics, Inc. will post -0.37 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $16.00 price target (up from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.